Citius Oncology, Inc. (CTOR)

CIK 1851484 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Citius Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Aug 26, 2026ARS0001213900-26-093758
Aug 26, 2026DEF 14A0001213900-26-093757
Aug 14, 20268-K0001213900-26-090182
Aug 14, 2026424B30001213900-26-090293
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003568
Aug 14, 202610-Q0001213900-26-090184
Aug 14, 202630002149660-26-000001
Aug 12, 20268-K0001213900-26-088068
Aug 5, 2026424B30001213900-26-085679
Aug 5, 20268-K0001213900-26-085434
Jun 5, 2026EFFECT9999999995-26-001912
Jun 4, 2026SCHEDULE 13D/A0001213900-26-065310
Jun 1, 20268-K0001213900-26-063530
Jun 1, 2026424B30001213900-26-063546
May 29, 2026S-30001213900-26-062864
May 29, 2026DEF 14C0001213900-26-062911
May 22, 2026424B30001213900-26-060571
May 19, 2026PRE 14C0001213900-26-059053
May 15, 202610-Q0001213900-26-057841
May 15, 2026SCHEDULE 13G/A0001172661-26-002138
May 15, 20268-K0001213900-26-057883
May 6, 2026424B30001213900-26-052840
May 6, 20268-K0001213900-26-052552
May 5, 2026424B30001213900-26-052124
Apr 29, 20268-K0001213900-26-049347